Ultrasound Contrast Agents: proceedings of the Oxford Conference, 1994 (supplement to Clinical Radiology, to be published 1995).
3.
Advances in Echocontrast, published quarterly by Kluwer.
4.
GramiakRShahPM, Echocardiography of the aortic root, Invest. Radiol. 1968, 3: 356–366.
5.
MattreyRFSteinbachGC. Ultrasound contrast agents: state of the art. Invest Radiol1991, 26:5–11.
6.
MattryRFStrichGSheltonREPerfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results. Radiol1987, 163:339–343.
7.
TenCateFJFeinsteinSBZwehlW1984Two-dimensional contrast echocardiography. II. Transpulmonary studies. Journal of American College of Cardiology1984;3:21–27.
8.
CrouseLJCheirifJHanleyDEOpacification and border delineation: improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the Phase III Albunex multicenter trial. Journal of the American College of Cardiology1993;22:1494–1500.
9.
SchliefRSchürmannRBalzerTSaccharide-based contrast agents and their application in vascular Doppler ultrasound. Advances in Echocontrast. 1994;3:60–76.
10.
GoldbergBBHilpertPLBurnsPNHepatic tumours: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology1990;177:713–717.
11.
KedarRPCosgroveDOMcCreadyVRBamberJC. Microbubble color Doppler angiography of breast masses: Dynamic and morphologic features of tumor vasculature - work in progress with Levovist. Radiol1995, (in press).
12.
UngarE.MRX-115, a double layered liposome ultrasound contrast agent, presented at RSNA ′94.
13.
SchwarzKQ. Quantitative Doppler Intensitometry. Advances in Echocontrast. 1994;4:11–12.
14.
BurnsP.Potential advantages of harmonic imaging. Advances in Echocontrast. 1994;4:17–18.